FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' lisdexamfetamine dimesylate as an original-application generic product under ANDA 217068.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)